冠昊生物 (300238.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(冠昊生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
主要指标:
 营业收入(元) 278,135,520.40189,698,181.6191,441,252.36404,178,697.25308,949,013.47210,814,871.09112,684,910.79
 营业利润(元) 31,497,237.7126,056,317.7920,520,473.3933,988,561.8044,354,392.3833,850,036.4327,754,942.39
 利润总额(元) 31,333,997.9525,878,411.9620,480,417.8832,089,194.4643,983,016.4933,893,615.2327,824,601.98
 净利润(元) 20,658,923.3016,759,336.2315,474,779.8421,072,537.5238,132,984.5530,205,873.7624,073,789.17
 归属于母公司股东的净利润(元) 27,836,338.5320,148,444.3314,391,514.7531,005,798.5841,271,327.2730,743,377.1722,115,265.70
盈利能力:
 销售毛利率(%) 78.6477.8278.0579.1380.4277.6077.28
 销售净利率(%) 7.438.8316.925.2112.3414.3321.36
 净资产收益率(%) 5.183.822.76----
 总资产报酬率ROA(%) 4.533.822.97----
 投入资本回报率ROIC(%) 4.643.422.475.617.505.574.00
营运能力:
 存货周转率(次) 0.830.600.29----
 应收账款周转率(次) 3.932.671.05----
 总资产周转率(次) 0.390.280.13----
偿债能力:
 资产负债率(%) 35.5032.9431.8832.7630.6832.2934.16
 股东权益比率(%) 74.8277.5577.2676.7277.7875.7673.40
 已获利息倍数(倍) 49.4064.30153.917.0019.4917.0758.04
 流动比率 1.671.791.841.551.911.831.72
 速动比率 1.141.251.281.071.321.331.24
发展能力:
 营业收入增长率(%) -9.97-10.02-18.857.135.093.91-8.33
 营业利润增长率(%) -28.99-23.02-26.07111.64119.16114.250.61
 税后利润增长率(%) -32.55-34.46-34.93110.07117.82112.601.54
 净资产增长率(%) 3.244.165.067.26-4.54-4.88-36.76
 总资产增长率(%) 7.331.76-0.191.24-14.40-14.09-37.40

前瞻产业研究院